In another study, in which PBMCs from patients with CL in Brazil were evaluated before and after leishmaniasis treatments, patients with active lesions were reported to have a high proportion of CD4+ T cells before the therapy; however, after their treatment and cure, the expansion of Leishmania-reactive CD8+ T cells was observed[43]. The gene discussed is CD4; the disease is leishmaniasis.